|
1
|
Tian Y, Yang W, Song J, Wu Y and Ni B:
Hepatitis B virus X protein-induced aberrant epigenetic
modifications contributing to human hepatocellular carcinoma
pathogenesis. Mol Cell Biol. 33:2810–2816. 2013. View Article : Google Scholar
|
|
2
|
Xu C, Zhou W, Wang Y and Qiao L: Hepatitis
B virus-induced hepatocellular carcinoma. Cancer Lett. 345:216–222.
2013. View Article : Google Scholar
|
|
3
|
Motavaf M, Safari S, Saffari JM and
Alavian SM: Hepatitis B virus-induced hepatocellular carcinoma: the
role of the virus x protein. Acta Virol. 57:389–396. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng SA and Lee C: Hepatitis B virus X gene
and hepatocarcinogenesis. J Gastroenterol. 46:974–990. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Assrir N, Soussan P, Kremsdorf D and
Rossignol JM: Role of the hepatitis B virus proteins in pro- and
anti-apoptotic processes. Front Biosci (Landmark Ed). 15:12–24.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kew MC: Hepatitis B virus x protein in the
pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
J Gastroenterol Hepatol. 26:144–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rawat S, Clippinger AJ and Bouchard MJ:
Modulation of apoptotic signaling by the hepatitis B virus X
protein. Viruses. 4:2945–2972. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J, Sun T, Park S, Shen G and Liu J: The
role of hepatitis B virus X protein is related to its differential
intracellular localization. Acta Biochim Biophys Sin (Shanghai).
43:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shoshan-Barmatz V, Israelson A, Brdiczka D
and Sheu SS: The voltage-dependent anion channel (VDAC): function
in intracellular signalling, cell life and cell death. Curr Pharm
Des. 12:2249–2270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rahmani Z, Huh KW, Lasher R and Siddiqui
A: Hepatitis B virus X protein colocalizes to mitochondria with a
human voltage-dependent anion channel, HVDAC3, and alters its
transmembrane potential. J Virol. 74:2840–2846. 2000. View Article : Google Scholar
|
|
11
|
Clippinger AJ and Bouchard MJ: Hepatitis B
virus HBx protein localizes to mitochondria in primary rat
hepatocytes and modulates mitochondrial membrane potential. J
Virol. 82:6798–6811. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XZ, Li D, Tao QM, Lin N and Chen ZX:
A novel hepatitis B virus X-interactive protein: cytochrome C
oxidase III. J Gastroenterol Hepatol. 21:711–715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li D, Wang XZ, Yu JP, Chen ZX, Huang YH
and Tao QM: Cytochrome C oxidase III interacts with hepatitis B
virus X protein in vivo by yeast two-hybrid system. World J
Gastroenterol. 10:2805–2808. 2004.PubMed/NCBI
|
|
14
|
Mkaouar-Rebai E, Ellouze E, Chamkha I,
Kammoun F, Triki C and Fakhfakh F: Molecular-clinical correlation
in a family with a novel heteroplasmic Leigh syndrome missense
mutation in the mitochondrial cytochrome c oxidase III gene. J
Child Neurol. 26:12–20. 2011. View Article : Google Scholar
|
|
15
|
Bauerfeld CP, Rastogi R, Pirockinaite G,
et al: TLR4-mediated AKT activation is MyD88/TRIF dependent and
critical for induction of oxidative phosphorylation and
mitochondrial transcription factor A in murine macrophages. J
Immunol. 188:2847–2857. 2012. View Article : Google Scholar
|
|
16
|
Liang L, Qu L and Ding Y: Protein and mRNA
characterization in human colorectal carcinoma cell lines with
different metastatic potentials. Cancer Invest. 25:427–434. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bafna S, Singh AP, Moniaux N, Eudy JD,
Meza JL and Batra SK: MUC4, a multifunctional transmembrane
glycoprotein, induces oncogenic transformation of NIH3T3 mouse
fibroblast cells. Cancer Res. 68:9231–9238. 2008. View Article : Google Scholar
|
|
18
|
Wu H, Rao GN, Dai B and Singh P: Autocrine
gastrins in colon cancer cells up-regulate cytochrome c oxidase Vb
and down-regulate efflux of cytochrome c and activation of
caspase-3. J Biol Chem. 275:32491–32498. 2000. View Article : Google Scholar
|
|
19
|
Soto IC, Fontanesi F, Valledor M, Horn D,
Singh R and Barrientos A: Synthesis of cytochrome c oxidase subunit
1 is translationally downregulated in the absence of functional
F1F0-ATP synthase. Biochim Biophys Acta. 1793:1776–1786. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Athar M, Chaudhury NK, Hussain ME and
Varshney R: Hoechst 33342 induced reactive oxygen species and
impaired expression of cytochrome c oxidase subunit 1 leading to
cell death in irradiated human cancer cells. Mol Cell Biochem.
352:281–292. 2011. View Article : Google Scholar
|
|
21
|
Bernstein C, Facista A, Nguyen H, et al:
Cancer and age related colonic crypt deficiencies in cytochrome c
oxidase I. World J Gastrointest Oncol. 2:429–442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gutierrez-Gonzalez L, Graham TA,
Rodriguez-Justo M, et al: The clonal origins of dysplasia from
intestinal metaplasia in the human stomach. Gastroenterology.
140:1251–1260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Szabo G and Lippai D: Molecular hepatic
carcinogenesis: impact of inflammation. Dig Dis. 30:243–248. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishida N, Arizumi T, Takita M, et al:
Reactive oxygen species induce epigenetic instability through the
formation of 8-hydroxydeoxyguanosine in human hepatocarcinogenesis.
Dig Dis. 31:459–466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Castello G, Costantini S and Scala S:
Targeting the inflammation in HCV-associated hepatocellular
carcinoma: a role in the prevention and treatment. J Transl Med.
8:1092010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hino K, Hara Y and Nishina S:
Mitochondrial reactive oxygen species as a mystery voice in
hepatitis C. Hepatol Res. 44:123–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Indo HP, Inanami O, Koumura T, et al:
Roles of mitochondria-generated reactive oxygen species on
X-ray-induced apoptosis in a human hepatocellular carcinoma cell
line, HLE. Free Radic Res. 46:1029–1043. 2012. View Article : Google Scholar
|
|
28
|
Lim W, Kwon SH, Cho H, et al: HBx
targeting to mitochondria and ROS generation are necessary but
insufficient for HBV-induced cyclooxygenase-2 expression. J Mol Med
(Berl). 88:359–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng AS, Chan HL, Leung WK, et al:
Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and
hepatocellular carcinoma: implication of HBx in upregulation of
COX-2. Mod Pathol. 17:1169–1179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bu X and Zhao C: The association between
cyclooxygenase-2 1195 G/A polymorphism and hepatocellular
carcinoma: evidence from a meta-analysis. Tumour Biol.
34:1479–1484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hernanz R, Briones AM, Salaices M and
Alonso MJ: New roles for old pathways? A circuitous relationship
between reactive oxygen species and cyclo-oxygenase in
hypertension. Clin Sci (Lond). 126:111–121. 2014. View Article : Google Scholar
|
|
32
|
Kiritoshi S, Nishikawa T, Sonoda K, et al:
Reactive oxygen species from mitochondria induce cyclooxygenase-2
gene expression in human mesangial cells: potential role in
diabetic nephropathy. Diabetes. 52:2570–2577. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nybo K: GFP imaging in fixed cells.
Biotechniques. 52:359–360. 2012. View Article : Google Scholar
|
|
34
|
Hu B, Tai A and Wang P: Immunization
delivered by lentiviral vectors for cancer and infectious diseases.
Immunol Rev. 239:45–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liechtenstein T, Perez-Janices N and
Escors D: Lentiviral vectors for cancer immunotherapy and clinical
applications. Cancers (Basel). 5:815–837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee YI, Hwang JM, Im JH, et al: Human
hepatitis B virus-X protein alters mitochondrial function and
physiology in human liver cells. J Biol Chem. 279:15460–15471.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang R, Kong F, Hu L, et al: Role of
hepatitis B virus X protein in regulating LIM and SH3 protein 1
(LASP-1) expression to mediate proliferation and migration of
hepatoma cells. Virol J. 9:1632012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khattar E, Mukherji A and Kumar V: Akt
augments the oncogenic potential of the HBx protein of hepatitis B
virus by phosphorylation. FEBS J. 279:1220–1230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng AS, Yu J, Lai PB, Chan HL and Sung
JJ: COX-2 mediates hepatitis B virus X protein abrogation of
p53-induced apoptosis. Biochem Biophys Res Commun. 374:175–180.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huh KW and Siddiqui A: Characterization of
the mitochondrial association of hepatitis B virus X protein, HBx.
Mitochondrion. 1:349–359. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hosler JP: The influence of subunit III of
cytochrome c oxidase on the D pathway, the proton exit pathway and
mechanism-based inactivation in subunit I. Biochim Biophys Acta.
1655:332–339. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Salvioli S, Bonafe M, Capri M, Monti D and
Franceschi C: Mitochondria, aging and longevity - a new
perspective. FEBS Lett. 492:9–13. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ray AM, Zuhlke KA, Levin AM, Douglas JA,
Cooney KA and Petros JA: Sequence variation in the mitochondrial
gene cytochrome c oxidase subunit I and prostate cancer in African
American men. Prostate. 69:956–960. 2009. View Article : Google Scholar
|
|
44
|
Ha HL and Yu DY: HBx-induced reactive
oxygen species activates hepatocellular carcinogenesis via
dysregulation of PTEN/Akt pathway. World J Gastroenterol.
16:4932–4937. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee YI, Hwang JM, Im JH, et al: Human
hepatitis B virus-X protein alters mitochondrial function and
physiology in human liver cells. J Biol Chem. 279:15460–15471.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bae SH, Jung ES, Park YM, et al:
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma
and growth inhibition of hepatoma cell lines by a COX-2 inhibitor,
NS-398. Clin Cancer Res. 7:1410–1418. 2001.PubMed/NCBI
|
